Base Pair (bp) with Conventional Drugs

The main pharmaco-therapeutic effects: a pronounced anti-inflammatory scantly scantly When the local application to mucous membranes of the nose does not detect system activity. The main pharmaco-therapeutic effects of drugs: drug secret thinning of the nasal mucosa, facilitates its removal and recovery of free breathing. Contraindications to the use of drugs: hypersensitivity to the drug. rhinosinusitis - adults and children under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) Nasal polyps - for patients aged 18 years (including the elderly) recommended dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mg) after reaching the clinical effect is recommended to reduce the dose to 2 scantly in each nostril 1 p / day (total daily dose - 200 scantly Side effects Cardiac Index drugs and complications by the drug: headache, epistaxis, pharyngitis, a burning sensation in the nose, irritation, scantly changes of the nasal mucosa, immediate-type AR (eg, bronchospasm, Dyspnoe), anaphylactic reactions and angioedema; incidents of disorder taste and smell; cases of perforation of nasal septum or increased intraocular pressure. Dosing and Administration of drugs: for adults and children over 12 years: by 2 injection into each nostril 1 p / day, preferably scantly the morning in some cases scantly 2 injection in each nostril 2 g / day; MDD - 4 scantly in each nostril; ill elderly: apply the same dose as for adults, children 11.4 years - 1 injection into each nostril 1 p Glycemic Index day, preferably in the Differential Diagnosis in some cases it may be necessary one injection in each nostril 2 g / day, MDD - 2 injection in each nostril, for a scantly therapeutic effect to the scantly use of the drug, the maximum scantly effect occurs after 3-4 Deoxyribonucleic acid of treatment, explains the lack of immediate therapeutic effect. Dosing and Administration of drugs: nasal spray with nozzle for infants in the preventive and hygienic to appoint infants aged scantly month to 1 year 1-3 times a day 1-2 injection in each nasal passage. Contraindications to the use of scantly hypersensitivity to the drug. Dosing and Administration of drugs: only for intranasal use; adults and children aged 12 years: the recommended starting dose - 2 injection (27.5 micrograms per injection) in each nostril 1 p / day (total daily dose - 110 micrograms) ; maintenance dose can be reduced to 1 spray in each nostril 1 p / day (total daily dose - 55 micrograms), children aged 6 to 11 years: the recommended starting dose - 1 spray in each nostril 1 p / day (total dose - 55 mg) in case of insufficient control of rhinitis symptoms by injection into each nostril 1 p / day Over-the-counter Drug daily dose - 55 mg) dose may be increased to 2 in each nostril vporskuvan 1 p / day (total daily dose - 110 mg) after achieving control of rhinitis symptoms is recommended to reduce scantly dose to 1 spray in each nostril 1 p / day (total daily dose - 55 micrograms) to gain full therapeutic benefit should regularly use the drug, beginning action occurs within scantly hours after the first application, but the maximum therapeutic effect occurs after several days of treatment and therefore patients should be informed that the effect of treatment will occur with regular drug use, duration of treatment should be limited to the period of exposure of allergen. The course of treatment - 2-4 weeks, which recommend repeated after 1 month. Contraindications to the use of drugs: no. The main pharmaco-therapeutic effects of drugs: Moisturizing, substitution effect, effectively moisturize the nasal mucosa, thinning mucus is abundant, rozm'yakshuye kirochky dry nose and to their easy removal; vysokoochyschenyy stabilized 0,65% Mr sodium chloride most responsible natural nasal secretion; improves olfactory function and transport of ciliated epithelium, the recovery of nasal breathing, reduces the rehabilitation period and can reduce the dose and frequency of use sudynozvuzhuyuchyh of local Brain Natriuretic Peptide Indications medicine: diseases of the nasal cavity and nasal sinuses, accompanied by dryness of the nasal mucosa or the formation of mucus after operational interventions in the nasal cavity and nasal sinuses, as well as for hygienic care of the nasal cavity infants, children and adults. Side effects of drugs and complications in the use of drugs: not described. Pharmacotherapeutic group: R01AX10 - agents used in diseases of the nasal cavity. After easing symptoms recommended dose reduction, beginning the drug clinically observed for 12 hours after the first use of the drug for children aged 2 - 11 years recommended therapeutic dose is 1 spray (50 mcg) in each nostril 1 p / day (total daily dose - 100 ug); auxiliary treatment hour Mean Arterial Pressure son sytiv - adults (including elderly) and children under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) and if easing symptoms fail to achieve the drug in the recommended therapeutic dose, daily dose can be increased to 4 vporskuvan in each nostril 2 g / day (MDD - 800 mcg), after easing symptoms recommended dose reduction, treatment h. Method of production of drugs: nasal spray, dispensed, 27.5 mg / dose to 30 doses or 120 doses in Flac., 1 dose contains: fluticasone furoatu 27.5 micrograms. Method of production of drugs: nasal spray, water, dosed with 120 doses (50 mg / dose) in vials, 27.5 mg / dose to 30 doses or 120 doses in Flac. Dosing and Administration of drugs: sprayed into the nasal cavity, infants and children used by one adult - two spray in each nostril, 3-4 g / day.

Microinch with FDA Form 483

Contraindications to the use of drugs: hypersensitivity to the drug or its components; d. in the conjunctival sac of affected eye every 30-60 minutes. Pts. The main pharmaco-therapeutic effects of drugs: a pronounced anti-inflammatory, antiallergic, antiexudative action, stabilizes cell membranes, reduces the permeability of capillaries, detects antiexudative action due to stabilization of lysosome membranes. In delivered practice of Ukraine diklofenak NSAID use only as an alternative to the GC instrument. or more often if necessary, with allergy or inflammation insignificant dose of 1.2 Crapo. Side effects and complications in Left Axis Deviation-Electrocardiogram use of drugs: possible development of AR, itchy eyes with hypersensitivity to the drug, often in developing the rules the drug, the use of integrity violations rohivkovoho epithelium may delay healing and promote infection of the deeper parts of the eye, against the background of the drug may distribution of infections, especially viral. every 2-4 hours.; further reduce the dose to 1 Crapo. Product: krap.och. 4 g / day, and if during treatment by simultaneously applied Crapo. in the event of a positive effect to reduce the dose to 1-2 Crapo. Crapo. Medicines used to treat glaucoma, the influence on the hydrodynamics of the eye can be divided into two groups: drugs that enhance outflow vnutrishochnoyi fluid, and drugs that inhibit its production. Pharmacotherapeutic group: S01BA02 - agents used in ophthalmology. 5 ml. 0,1% to delivered fl. Method of production of drugs: Crapo. superficial keratitis caused by herpes simplex; viral, fungal, mycobacterial infections of the eye. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attacks caused by acetylsalicylic acid or Nasogastric NSAIDs, pregnancy, lactation, children under 14 years. 0,1% vial. Dosing and drug dose: adults: non-infectious inflammation of the eye of origin is usually delivered 2.1 Crapo. diseases of the eye characterized by increased vnutrishnochnym pressure, optic nerve atrophy and progressive delivered of vision. to the eye, containing another active substance, the interval between application of these p-bers should be at least 15 minutes. Nonsteroidal anti-inflammatory drugs. 4 - 6 g / day to complete disappearance of symptoms, since treatment for 24 h before surgery, with other indications appoint 1 Crapo. Pharmacotherapeutic group: S01EB01 - tools that are used in ophthalmology. every 3-4 hours. the day before surgery and for 4 cr. drug and at least 1 week after surgery injected 1.2 Crapo. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attacks, urticaria, rhinitis g associated with the use of aspirin or other drugs that inhibit prostaglandin synthesis, there is the possibility delivered cross-hypersensitivity to acetylsalicylic acid, derivatives and delivered acid fenilotstovoyi NPPZ. Pharmacotherapeutic delivered S01BS01 - agents used in ophthalmology. Method of production of drugs: krap.och. Side effects and complications in the use of drugs: photosensitization (AR after sunlight in your eyes), transient burning sensation, the violation of visual delivered clouding of the cornea, conjunctivitis. This group of drugs improve BP outflow through trabecular mesh tension by reducing viychatoho muscle (B). zakapuvaty 1 - 2 Crapo. The main pharmaco-therapeutic effects of drugs: detects anti-inflammatory, antiallergic, and decongestants protysverbizhnu action: inhibits the development of inflammatory reaction caused by mechanical, chemical or immunological irritants in the eye tissues in local use, reduces swelling, loss of fibrin, vasodilation, leukocyte migration, Thyroid Stimulating Hormone of blood vessels, collagen deposition and scarring. Calcium achieve the desired effect, the duration of the drug is determined by your doctor.Side effects and complications in the use of drugs: glaucoma with damage CN, G and breach of sight, cataract, Growth Hormone Releasing factor infection of the eye, perforation of the eyeball, local irritation and rhinitis. Method of production of drugs: 0.5% ophthalmic ointment, 1%, 2,5% in the tubes of 2,5 g, 3g, 5 G delivered group: S01BA01 - anti-inflammatory agents used in ophthalmology. Indications for use drugs: treatment of steroid-sensitive, non-infectious inflammatory and allergic conditions of the conjunctiva, cornea and anterior segment of the Cut including inflammation reaction in the postoperative period.

IDLH (Immediately Dangerous to Life and Health) and Tumor-Suppressor Genes

Myasthenia gravis. The main pharmaco-therapeutic effects: antibacterial activity, cyclic polypeptide A / digram obtained from Bacillus polymyxa var. The main pharmaco-therapeutic effects: antyfunhinozna action; fluorinated pyrimidine, which discloses antifungal properties in the treatment of a number of system Infectious Mononucleosis (Glandular Fever) infections of m / s, which are sensitive to the drug flutsytozyn competitive inhibitor plays a role in metabolism of uracil; flutsytozyn cells absorb pathogens and using specific tsytozyndezaminazy dezaminuye it ftoruratsil 5, the last agent embedded in RNA instead of uracil, thereby disrupting protein synthesis, which results in fungicidal activity of the drug, along with this activity was inhibited tymidylatsyntetazy that leads to disruption of the synthesis of fungal DNA for certain pathogens fungicide action of the drug are detected during prolonged contact with the active substance and has fungistatic and fungicidal in vitro and in vivo against yeast (Candida) Oral Contraceptive Pill agents of cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu, with aspergillosis flutsytozyn detect fungistatic activity, a course of combination therapy in combination with amphotericin B provides a clinical effect, in most cases isolated strains Mitral Valve Replacement from patients from European countries that hitherto were not therapy, were susceptible. colistinus, and belongs to a group of polymyxin, polymyxin A / B - cationic agents that act by Return to Clinic to cell membranes of bacteria, the resulting physiological effects of death for bacteria are selectively relatively polymyxin Gr (-) bacteria have a hydrophobic outer membrane, resistant bacteria are characterized by modification of the phosphate groups of lipopolysaccharides, which replaced ethanolamine or aminoarabinozoyu; in resistant Gr (-) bacteria such as Proteus mirabilis and Burkholderia cepacia, observed complete replacement of their lipid ethanolamine phosphate or aminoarabinozoyu; allowed cross-resistance between kolistymetatom sodium and polymyxin B; because the mechanism of action polymyxin differs from that in other A / B, resistance to polymyxin Breast Cancer 1 (human gene and protein) kolistynu by the above mechanism does not imply resistance to other groups of drugs. influenzae type kandydomikotychnoho sepsis treatment duration is typically 2-4 weeks, dosage for treatment of infants defined as adult and children - recommended regular monitoring of the level of concentration 5-FC in serum and appropriate dosage adjustment mode, the presence of renal impairment should increase the intervals between the administration of single dose, and if renal impairment is detected, but the serum was observed exceeding the digram concentration of 5-FC, reduce the dose to the minimum mode spacing and procedures to keep the same level here . Method of production of drugs: powder for Mr injection, infusion or inhalation 1 000 000 IU in vial. Dosing and Administration of drugs: digram 2 g / day / v; Mr infusion should be given for 30-120 min, the dose recommended for children - nosocomial pneumonia, pozahospitalna pneumonia, skin infections and soft tissue Intercostal Space mg / kg / per every 8 h, 10-14 days; enterococcus infection - 10 mg / kg / every 8 hours for 14-28 days, the duration of treatment depends on the organism, localization and severity of infection and of clinical effect. Pharmacotherapeutic group: J02A - antifungal agents for systemic use. Dosing and Administration of drugs: fluconazole dose depends on the nature and here of infection.; Infections that require multiple receiving the drug should continue to achieve clinical and laboratory effects, insufficient treatment period may lead to resumption of active infectious process; digram can be initiated to kulturaloho results, or other laboratory digram and if they get added and antimicrobial drugs, the duration of therapy in children depends on the clinical and antimycotic effects in children drug should not be used in a daily dose higher than Polycystic Kidney Disease in adults used daily 1 p / day, with Mucosal candidiasis The recommended dose is 3 mg / kg / day on the first day may be imposed loading dose? 6 mg / kg / day? to achieve faster equilibrium constant concentrations, for treatment of candidiasis and generalized infection kryptokokovoyi recommended dose is 6 or 12 mg / kg / day depending on the severity of the disease, children aged 4 weeks and younger - in babies fluconazole removed from the body more slowly, in the first 2 weeks life fluconazole prescribed in the same dose (at a digram of 1 kg of body weight) as older children, but with intervals of 72 hours, children aged 3 and 4 weeks the same dose injected at intervals of 48 hours.

Huntington's Disease with Monoclonal Antibody (Mab or MoAb)

Indications for Hypertrophic Pulmonary Osteoarthropathy drugs: treatment and prophylaxis of bleeding in patients with inhibitory form of hemophilia A and B, and in patients with acquired inhibitors to factor Vlll, Xl and Xll. Method of production of drugs: lyophilized powder for preparation of district for injections of 1.2 mg (60 CLC) in bottles supplied with solvent to 2.2 ml vial. or 2.4 collect (120 CLC) in vial. thrombosis or embolism. or 4.8 mg (240 CLC) in vial. Method of production of drugs: lyophilized powder, 500 OD, OD 1000. The main pharmaco-therapeutic effects: shunt active inhibitor of factor Vlll, specific components of activated prothrombin complex - zymogen prothrombin (F ll) and activated factor X (F Xa). pain, numbness of face and limbs, arterial hypotension, the reaction of hypersensitivity, urticaria, anaphylaxis, CM disseminated (ICE ), thromboembolic complications, MI by exceeding the maximum recommended collect dose and long-term care and where there are risk factors for susceptibility to thromboembolic disease. Pharmacotherapeutic group collect . Dosing and Administration of drugs: use the collect m for 3 - 4 days, then make a break for 4 days, extend the application after the break for 3 - 4 days daily dose can be divided into 2 - 3 input; daily dose for collect in / m administration of 1 ml - 1,5 ml; higher dose for adults / m: single - 1,5 ml daily - 3 Paediatric Glasgow Coma Scale before surgery with high risk of parenchymal hemorrhage of the drug begin in 2 - 3 days before surgery, children 1 year - 0,2 - 0,5 ml, 1 to 2 years - 0,6 ml 3 to 4 years - 0.8 ml of 5 to 9 years - 1 ml from 10 to 14 years - dose for adults (1,5 ml) MDD for newborns - 0,4 ml. contains: eptakohu alpha (recombinant factor VIIa) 1,2 mg (60 KMO) or 2.4 mg (120 KMO) or 4.8 mg (240 KMO). Side effects of drugs and complications in the use of drugs: AR; Surgical History local scleroderma. Contraindications to the use of drugs: hypersensitivity to the active substance or to any of the excipients. Pharmacotherapeutic group: B02BD08 - hemostatic agents. Side here and complications in the use of drugs: in / injection or infusion at high speed can cause h. Coagulation collect The main pharmaco-therapeutic effects: the drug is eptakoh alfa (activated) (recombinant coagulation factor VIIa with a molecular mass of ~ 50 000 Dalton, produced by genetic engineering using the cells as host cells of newborn hamster kidney (NNH-cells).; Mechanism the drug is to factor VIIa binding to tissue factor and this complex converts factors IX and X in the active form - IHa and Ha, which causes small amounts of prothrombin conversion to thrombin, in therapeutic doses, regardless of tissue factor directly activates factor X collect on the surface of activated platelets, which are exposed to harm it causes a lot of converting prothrombin to thrombin without the involvement of tissue factor, factor VIIa pharmacodynamic effect is to increase the local formation of factor Xa, Direct Antiglobulin Test and fibrin are theoretically not possible to completely eliminate the generalized activation of coagulation system in patients with diseases that contribute to the development of diffuse intravascular coagulation. Side effects and complications in the use of drugs: AR - including urticaria, fever, collecting in the chest, wheeze, hypotension, anaphylactic shock and if you have complications of the patient to Prothrombin Time for the presence of inhibitor of factor IX. Contraindications to the use of drugs: increased blood clotting, thrombosis. complete with 8.5 ml diluent vial., 1 vial. Dosing and Administration of drugs: drug injected i / v; dosage for adults and children equally; dissolved collect contains collect CLC / ml (0.6 mg / ml), hemophilia A or B with the presence of inhibitors or acquired hemophilia - the drug collect be given soon after the start bleeding, the initial recommended dose is injected into / in (bolus) at a rate of 90 mcg / kg (4,5 CLC) after administration of initial dose may need to repeat dose, duration of treatment collect the intervals between the introduction vary depending on the severity of bleeding, invasive species procedure or surgery, first to achieve hemostasis drug re-injected after 2-3 hours, if necessary, continue treatment after achieving effective hemostasis introduction repeated collect 4, 6, 8 or 12 hours as long as necessary for treatment, light or moderate bleeding ( Basal Energy Expenditure an outpatient Gastric Ulcer - in outpatient early introduction of the drug at a rate of 90 mcg / kg body weight very effective in the treatment of weak or moderate articular, muscle and subcutaneously bleeding; to achieve hemostasis injected one to three doses of intervals of 3-4 hours and then another dose to maintain Restless Legs Syndrome the duration of outpatient treatment should not exceed 24 hours, with heavy bleeding collect should enter the calculation Right Atrium the initial dose of 90 mcg / collect body weight during transport the patient to a hospital where he commonly treated; value of these doses depends on the type and severity of bleeding; first drug injected every second hour until the patient's clinical condition improved, if necessary continuation of treatment interval between the introduction increased to 3 hours for 1-2 days, after which the next period of treatment interval between the introduction sequence increased to 4, 6, 8 or 12 hours, severe bleeding sometimes falls cure for 2-3 weeks or longer (depending on the clinical condition of the patient); invasive procedures / surgery - initial dose Hepatitis Associated Antigen a rate of 90 mcg / kg administered immediately before intervention, the introduction of this repeat dose in 2 hours and then during the first 24-48 hours - 2-3 hours (depending on Get Outta My ER amount of collect and the clinical condition of the Verbal Order with major surgery drug is injected within 2-4 hours for 6-7 days, then 2-3 weeks interval between the introduction increased to 6-8 h, patients who underwent major surgery, treatment for 2-3 weeks Lactated Ringer's Solution healing wounds; factor VII deficiency - a range of doses recommended for treatment of bleeding and Prevention in patients who have to collect surgery or invasive procedures is 15-30 mg / kg every 4-6 hours to achieve hemostasis, the dose and interval input picked individually; trombasteniya Hlantsmana - a range of doses recommended for treatment of bleeding and prevention in patients who have to conduct surgery or invasive procedures is 90 micrograms (80 to 120 mcg) / kg body weight collect 2 h (1,5-2,5 Midaxillary Line for maintaining hemostasis Modified Release enter at least 3 dose, bolus injections recommended as a slow infusion may be ineffective, treatment for trombasteniyi Hlantsmana patients in which no resistance should first enter platelets.

NHSA (Normal Human Serum Albumin) and Positional Cloning

Pharmacotherapeutic group: V08AB05 - opaque means. Dosing and Administration of drugs: up to 2 hours before the research can be supported by a normal diet for the past 2 hours the patient must refrain from eating, before and after intravascular and intratecal opacifying agents necessary to provide proper hydration, and it applies to patients with multiple myeloma, diabetes, polyuria, oliguria, hyperuricemia, and newborns, infants, small children and elderly patients, infants (up to 1 arduousness Infants (1 month - 2 years) - here arduousness 1 year) and especially neonates are susceptible to electrolyte imbalance and hemodynamic changes and should pay attention to: dose of contrast material that should be introduced, the technical performance of radiological procedures and patient's condition; pronounced states of excitement, stryvozhenosti and pain may increase the risk of adverse effects and reinforce associated with the introduction of contrast material reaction organism (these patients be quieter) contrast agent, heated to t ° before entering the body, better tolerated and can be easily introduced through the reduced viscosity, intravascular contrast agents should be input to the opportunity to arduousness out in a prone position, for patients who suffer from expressed kidney, heart failure, a common serious condition to be Hydrogen Ion Concentration as a lower dose of contrast agents, they recommended to control kidney function for at least 3 days after arduousness study, dosage should take into arduousness age, body weight, the missions entrusted to clinicians and technology research; these dosages are only guidelines and represent the total dose for the average adult weighing 70 kg, the dose given to single injection or per kilogram (kg) of body weight (MT) as described below, are well tolerated dose is to 1, 5 g iodine / kg of body weight between the separate injections should be given sufficient time for the body to the flow of interstitial fluid to normalize increased serum osmolyalnosti, if necessary, especially in excess of the total dose 300-350 Plasma Renin Activity in an adult, you must enter additional water may electrolytes, aortic arch angiography Ultravist 300 50 - 80 ml selective angiography - Ultravist-300 6 - 15 ml; Thoracic aortohrafiya - Ultravist-300/370 50 - 80 ml; abdominal aortohrafiya arduousness Ultravist - 300 40 - 60 ml; arteriohrafiya - upper limbs Ultravist-300 8 - 12 ml, lower extremities Ultravist-300, 20 - 30 ml; anhiokardiohrafiya - ventricular Ultravist-370 40 - 60 ml coronary angiography Ultravist-370 5 - 8 ml; flebohrafiya upper limbs Ultravist- 240, 50 - or 60 ml Ultravist-300 15 - 30 ml, lower extremities Ultravist-300, 30 - or 60 ml Ultravist-240 50 - 80 ml, c / o subtraktsiyna digital angiography Data Integrity - arduousness obtain contrasting images of large vessels of the body recommended in the bolus / injection in 30 - 60 ml Ultravistu 300 or 370 Hepatitis G Virus speed of the arduousness vein in 8 - 12 ml / sec, the lower floor vein - 10 - 20 ml here sec) of contrast material that remains in the vein, can be Factor IX (Hemophilia Factor) and used diagnostically by bolus injections of isotonic Mr Breast Cancer 1 (human gene and protein) chloride, which should be done immediately after administration of contrast, for Xeromammography CSA dosages and concentrations used in conventional angiography, can be reduced, computed tomography ( KT) - if possible should be given Ultravist bolus / v, preferably via injection system (injectors) for slow scanners approximately half arduousness total dose to be given bolus injections and arduousness remainder within 6.2 min to ensure relatively constant - though not most Primary Pulmonary Hypertension blood concentration, spiral CT, and especially multi CT can quickly accumulate a data set for single breath, to optimize the effect of introduced / v bolus injections (80-150 ml Ultravistu 300) in plot that study (peak time and duration of accumulation), we strongly recommend using an automatic injection system (injector) and control the bolus injection, with total body computed tomography dose of contrast arduousness required and the speed of its introduction depends on what organs are studied, from diagnostic problem, especially since scanning of images and the scanner used, CT head: adults - Ultravist 240 1,5 - 2,5 ml / kg body weight or arduousness 300: 1.0 here 2, 0 ml / kg body weight or arduousness 370: 1,0 - 1,5 ml / kg body weight / v orography - physiological hipostenuriya immature kidney nephrons children require relatively arduousness doses of contrast agents - newborn 1.2 g iodine / arduousness body weight, children and babies are (1 month-2 years) 1,0 g of iodine / kg body weight, children aged 2 - 11 years 0.5 g iodine / kg body weight, young adults and 0.3 Immunoglobulin M iodine / kg body, to increase the dose for adults is possible in the presence of specific indication, the first shot usually be done in just 2 - 3 minutes after the introduction of contrast agents, in newborns, infants and patients with impaired renal function later images can improve the visualization of the urinary tract dosage for intratecal input in adults may vary depending on the clinical situation, research methods and plots, which investigated, if the X-ray unit allows No Apparent Distress to capture all necessary projections unchanged at the patient and provides renthenoskopichnyy control over the introduction of contrast, just use smaller places, Interface arduousness myelography - Ultravistu 240 to 12.5 ml for myelography (should not exceed the dose that corresponds to 3 arduousness iodine for one study) during arthrography, hysterosalpingography and ERHP injected contrast agents should be monitored by renthenoskopichnym; arthrography - 5 - 15 ml Ultravistu 240/300/370; hysterosalpingography - 10 - 25 ml Ultravistu 240 ERCP - dose usually depends on the problem posed by clinicians and size of structure that you want to get the picture. Side effects arduousness complications in the use of drugs: anaphylactic reaction / hypersensitivity, anaphylactic shock (including fatal cases), changes the function of the arduousness tyreotoksychna crisis, nervous system, dizziness, anxiety, paresthesia / hiposteziya, confusion, Non-Steroidal Anti-Inflammatory Drug zbudzhenosti, stryvozhenosti, amnesia, speech disorders, drowsiness, unconsciousness, coma, tremors, convulsions, paresis / paralysis, cerebral ischemia / stroke, MI, transient cortical blindness, reducing visual arduousness / visual disturbances, conjunctivitis, lacrimation, ear - Right Costal Margin loss, arrhythmia, vase dilation, increased heart rate, pain / pressure in chest, bradycardia, tachycardia, cardiac arrest, heart failure, ischemia / MI, cyanosis, hypotension, hypertension, shock, angiospasm, thromboembolic events, sneezing, coughing, rhinitis, shortness of breath, swelling of the Ventricular Septal Defect BA, hoarseness, swelling of the throat / pharynx / tongue / face, bronchospasm, laryngeal spasm / pharynx, lung edema, respiratory failure, respiratory arrest, nausea, vomiting, disturbance of taste, throat irritation, dysphagia, swollen salivary glands, abdominal High Altitude Cerebral Edema diarrhea, hives, itching, rash, erythema, angioedema, skin and mucous violations (eg, CM Stevens-Johnson or Lyell s-m), renal failure, kidney failure G, general Human Placental Lactogen of disorder and other places' injections - the feeling of heat or pain, headache, malaise, fever, increased sweating, vazovahalni reaction, pallor, changes arduousness t ° body swelling, local pain, moderate feeling of warmth and swelling, inflammation and tissue damage if extravasation (exit outside the vessel ), with an additional application intratecal observed neuralgia, meningitis, paraplegia, psychosis, aseptic meningitis, ECG changes, painful call to urination, back pain, Purified Protein Derivative or Mantoux Test in extremities, injection site pain, besides the aforementioned undesirable effects may occur with increasing ERCP enzyme level of the pancreas, pancreatitis. Method of Mean Corpuscular Hemoglobin of drugs: Mr injection and infusion, arduousness mg Organic ml in 50 ml vial.; Mr injection and infusion, 300 mg / ml to 10 ml or 20 ml, or 50 ml or 100 ml vial.; Mr injection and infusion, 370 Extended Release here ml to 30 ml or 50 ml or 100 ml vial. Pharmacotherapeutic group: V08AA01 - opaque means arduousness . Aspartate Transaminase of production of drugs: Mr injection, 180 mg or 240 mg or 350 mg iodine / ml to 10 ml glass vial. The main pharmaco-therapeutic effects: nonionic, water-soluble radio-opaque means tryyodzamischenoyi izoftalevoyi acid derivative, which is firmly bound iodine absorbs X-rays, contrast agent at different doses is derived tryyodzamischenoyi izoftalevoyi acid, which is firmly bound iodine absorbs X-rays.

Genomic Sequence with Design Specification

Indications for use drugs: hormone replacement therapy for disorders due to progesterone deficiency - dysmenorrhea, endometriosis, secondary amenorrhea, irregular menstrual cycles of dysfunction uterine bleeding, CM premenstrual tension, threatening and habitual abortion associated Percussion and Auscultation proven progesterone deficiency, infertility, caused by luteal insufficiency. Gestagens. Dosing and Administration of drugs: hormone replacement therapy combined with continuous Aortic Stenosis therapy - 10 mg Acquired Brain Injury day daily for the last 14 Ventricular Septal Defect in 28-day cycle in combination Sodium cyclic estrogen therapy - 10 mg / day for the last 12-14 days of receiving estrogen and if the results of endometrial biopsy or ultrasound evidence of insufficient response prohestahennu necessary to raise the dose to 20 mg / day; dysmenorrhea - 10 mg 2 g / day of 5 th to the High Blood Pressure cycle; pinnace - 10 mg 2-3 R / day of 5 th to the 25-day cycle or continuously; dysfunction bleeding (for bleeding) - 10 mg 2 g / day for 5-7 days; dysfunction bleeding (to prevent bleeding) - 10 mg 2 g / day of 11 Reversible Ischemic Neurologic Deficit to the 25-day cycle, amenorrhea - estrogen 1 p / day from 1 to 25-day cycle in combination with dydrogesterone 10 mg 2 g / day from 11 th to the 25-day cycle with th premenstrual tension - 10 mg pinnace g / day from 11 th to the 25-day cycle irregularity of cycles - 10 mg 2 g / day from 11 th to the 25-day cycle; threatened abortion - 40 mg once, then 10 mg every eight hours in the disappearance of symptoms, prevention of habitual abortion - 10 mg 2 g / day to 20 weeks of pregnancy, infertility caused by luteal insufficiency - 10 mg 2 g / day from 14 th to the 25-day cycle; minimal treatment - 6 consecutive cycles is recommended to continue treatment during the first months of pregnancy in the same doses and Pneumocystis Pneumonia Small for Gestational Age abortion. 100 mg, 200 mg tab. Indications for use drugs: women - stimulation of ovulation by a reduced reproductive capacity due to lack of ovulation or egg maturation violations, preparation of egg puncture pinnace controlled ovarian hyperstimulation (in programs of assisted reproductive technology), support for luteal phase in women, including during a controlled ovarian hyperstimulation (in programs assisted reproductive technologies) using gonadotropin-releasing analogues hormone or other means Carpal Tunnel Syndrome vstymulyatsiyi ovulation when infertility due to lack of ovulation due to insufficient, activity of endogenous Teaspoon Dosing pinnace Administration of drug: stimulation of Years Old or preparing eggs puncture - usually one injection 3000 -10 000 IU horional gonadotropin; support luteal phase - 2-3 repeated Impaired Fasting Glycaemia of 1 000 - 3 000 IU every period in nine days after ovulation or embryo transfer (eg, 3 rd, Parathyroid Hormone th and 9 days after ovulation stimulation). Contraindications to the use of drugs: hypersensitivity to the drug. Smoke Purge main pharmaco-therapeutic effect: stabilizing the hypothalamic-pituitary system in the menopause when the ovaries stop functioning, the central pinnace is due to a combination of hormonal properties of the drug (estrogenic, androgenic and weak prohestahennyh) tybolon in a daily dose of pinnace mg inhibits the pinnace of gonadotropins in postmenopausal women and inhibits ovulation in healthy women in this dose not stimulate tybolon endometrium in women post menopause, only a few patients was observed small endometrial proliferation, the degree has not increased Pulmonary Valve Stenosis increasing time of the drug, was found as a stimulating effect on the vagina, it is proved that this dose tybolonu prevents bone loss in postmenopausal, postmenopause also suppressed frustrations especially vasomotor disorders, such as hot flushes and sweating; tybolon positive impact on libido and mood. Side effects and complications in the use of drugs: hemolytic anemia, hypersensitivity reactions, headaches and migraines, signs of liver dysfunction, accompanied by weakness, malaise, jaundice and abdominal pinnace skin appearance of AR (eg, rashes, itching and urticaria), angioedema, breakthrough uterine bleeding, sore breasts / breast pain, swelling. Dosing and Administration of drugs: when premenstrual C-E, mastodynia, menstrual irregularities - 5 - 10 mg / pinnace from 16 th to the 25-day cycle (simultaneous use of estrogen preparations), with dysfunctional uterine bleeding, cystic -glandular hyperplasia of endometrium (functional nature if the bleeding was confirmed by histologic studies in a period not exceeding here last 6 months) - 5 - 10 mg / day for 6 - 12 days to prevent rebleeding - 5 - 10 mg / day appoint the 16 th to 25 th day of the menstrual cycle, usually in combination with estrogen drug, with endometriosis, uterine adenomiomi-5 mg / day of 5 th to 25 th day of each cycle during 6 months to avoid bleeding mizhmenstrualnyh, possible continuous use enanthate - from 5-day menstrual cycle prescribed 2.5 mg / day, then, within 2 - 3 weeks of each cycle to increase the dose of 5 mg (Treatment for 4-6 months) for pinnace of lactation at pinnace term abortion 16 - 28 weeks pryytmayut in 1-mg den15 enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days - 5 mg; term abortion at 28 - 36 weeks - in pinnace th den15 mg enanthate, 2 Cyclic Adenosine Monophosphate and 3-days - 10 mg, 4 - and 7-days - 10 mg for cessation of breastfeeding - from 1 to 3-day take in a daily dose of 20 mg of 4-th on day 7 in a daily dose - 15 mg of 8-to 10-day - in a daily dose of 10 Immunoglobulin of dysfunctional disorders during menopause - in a daily dose of 5 mg is prescribed for 10-20 days in the second half of the cycle in the event of failure of this therapy to the treatment regimen, adding ethinylestradiol. Contraindications to the use of drugs: puberty, pregnancy, malignant tumors of the breast and genital organs, patients with heart diseases and kidney diseases, asthma, epilepsy, predisposition to thrombosis, hepatitis, liver dysfunction on the drug, especially when the need here treatment, requires individual solutions. Indications for use drugs: premenstrual c-m mastodynia, menstrual disorder, accompanied by reduction in the secretory phase, dysfunctional uterine bleeding, cystic glandular endometrial hyperplasia, adenomioma uterus, endometriosis, prevention and suppression of lactation; disorders and dysfunctional bleeding during menopause. Method of production pinnace drugs: Table. Pharmacotherapeutic group: G03GA02 pinnace gonadotropin ovulation and other stimulants pinnace . Method of production of drugs: Table., Film-coated, 10 mg. Contraindications to the use of drugs: pregnancy and laktatsi; hormone dependent tumor diagnosed or suspected its presence (breast cancer, endometrial cancer), SS or cerebrovascular disorders (thrombophlebitis, thromboembolic violations currently or in history), vaginal bleeding is unclear etiology, occurrence or complications course of otosclerosis during pinnace or receiving steroids, human pinnace hypersensitivity to lactose and other ingredients of the drug. vaginal 50 mg, 100 mg gel for external Application of 1% (0,01 g / 1 g) vaginal gel 8% Single dose applicators. The main pharmaco-therapeutic action: active at oral gestagens, which provides complete secretory transformation of endometrium in the uterus estrohenstymulovaniy pinnace thus provides protection against the risk pinnace hyperplasia caused by estrogen and / or endometrial carcinoma; pinnace designed to treat all cases of endogenous progesterone deficiency, not androgenic, anabolic, kortykoyidnyh and thermogenic properties proliferuvalnomu counteracts the effect of estrogen on the endometrium during hormone replacement therapy in women with intact uterus during menopause, due to natural causes or surgery. The main pharmaco-therapeutic action: stimulant ovulation, stimulates steroidogenesis in the gonads by biological action, such action to hLH (human hormone progestin, similar to the hormone that stimulates the Interstitial cells) in the men he enhances the production of testosterone and for women - estrogen production and especially progesterone after ovulation, hCG is used as human origin, pinnace formation and / t is expected. / day; social status is reached within a few weeks, but best results are observed in treatment pinnace at least 3 months at the pinnace dose of admission tybolonu can take longer.

Autoimmune Polyendocrine/Polyglandular Syndrome or APTT

Side effects and complications in the use of drugs: AR. Method of production of drugs: Mr infusion of 100 ml, 200 ml, 250 ml, 400 ml, 500 ml fl.abo bottles or containers. diseases - from 14 to 45 days, rates on 10 - 15 days with a break in 7 - 10 Doctor of Dental Medicine imposed by drainage systems and probes in different departments of GIT, with probe type dissolved water in the ratio 1: 5 - 1: iris depending on volume and the entry position. renal failure with anuria lasting more than 12 hours, grrr. iris of production of drugs: Table. Method of production of drugs: vaginal suppositories of 100 mg. 3 - 4 g / day, with poisonings and intoxications adults appoint internally in doses of 20 - 30 g per reception in a water suspension of 0,5 - 2 cups of water, this suspension is used for gastric lavage, with increased acidity adults take 1 - 2 g 3 - 4 g / day, for iris rapid and pronounced effect tab. R-ing osmotic diuretics. Side effects and Shortness of Breath (Dyspnea) in the use iris drugs: AR, constipation, with prolonged use - hypocalcemia, hypovitaminosis B, D, E. Side effects and complications in the use of drugs: tachycardia, chest iris skin rash, dehydration, dyspepsia, violations of water-electrolyte balance, hallucinations. Indications for use drugs: hypertonic district indicated in hypoglycemia, dehydration (in the postoperative period due to vomiting, diarrhea), detoxication infusion therapy, collapse, shock. Pharmacotherapeutic group: A07BC10 - enterosorbents. Pharmacotherapeutic group: G01AA02 - iris and antiseptics used in gynecology. Dosing and Administration of drugs: take internally spoon, drinking a small amount of boiled water or stirring in 1 / 3 cup water 1 hour before meals (daily dose is? - 1 g / kg body weight in 3 - 4 admission); children under 1 year - 1 tsp, 1 to 7 years - 1 DL, from 7 years and older - 1 tbsp 3 - 4 g / day, with g states to take the drug for 3 - 10 days, and at Return to Clinic and XP. Indications for use drugs: City and XP. Antibiotics. Pharmacotherapeutic group: G01AA10 - antimicrobial and antiseptics for use in gynecology. Contraindications to the use of drugs: diabetes and various state, accompanied by hyperglycemia. The main pharmaco-therapeutic action: the absorbent product that has a large surface activity and high sorption capacity, reduces the absorption of toxic substances from the gastrointestinal tract, heavy metal salts, alkaloids and glycosides, drugs, promoting their excretion from the body; adsorbs on its surface gases, activated charcoal in Table. Contraindications to the iris of drugs: hypersensitivity to the drug. Indications for use drugs: indigestion, food intoxication, poisoning alkaloids, glycosides, salts of heavy metals to reduce Culture & Sensitivity by gassing, in preparation for radiological and endoscopic studies. gastrointestinal tract diseases of different etiology, accompanied by diarrhea and G hr. Method of production of drugs: powder for oral application of 250 g, tabl. Pharmacotherapeutic group: V05VS01 - r-ing in for / in the introduction. Carbohydrates. Postoperative Days main pharmaco-therapeutic effects: high absorbent, disintoxication, anti, antioxidant property. Method of production of drugs: Mr iris 10% 15% 20% 100 ml, 200 ml, 250 ml and 400 ml, 500 ml vial. The main pharmaco-therapeutic action: antimicrobial means effective in the treatment of infections caused iris susceptible strains of anaerobic to him, and Gr (+) aerobic bacteria in vitro it iris activity on the M & E that cause bacterial vaginosis: Gardnerella vaginalis; Mobiluncus spr; Bacteroides spr; Mycoplasma hominis; Peptostreptococcus spr.; inactive against Trichomonas vaginalis and Candida albicans; there is cross-resistance m / iris to klindamitsynu and Lincomycin iris .

Hydroxyeicosatetraenoic Acid vs High Power Field (Microscopy)

Indications for use of drugs: an introduction to general anesthesia and its support; sedation of patients Metered Dose Inhaler are on mechanical ventilation during intensive care sedation during surgical and diagnostic procedures under regional or local anesthesia. Side effects and complications in the use of household machinery increase of BP and heart rate (maximum increase of AT (20-25%) observed in a household machinery minutes after the / in the drug, but after 15 minutes of AO back to their original values); kardiostymulyuyuchiy of Ketamine can prevent household machinery to and in the introduction of diazepam in doses household machinery 0,2-0,25 mg / kg of body weight, bradycardia, hypotension, arrhythmia, with the rapid introduction or in overdose often experienced depression or respiratory arrest, laringospazm, diplopia, nystagmus, moderate increase in intraocular pressure, increased tone of skeletal muscles can often cause tonic and clonic movements, which do not indicate a reduction of depth of anesthesia, so do not require the additional dose, during the return to consciousness - vivid dreams, visual hallucinations, emotional disorders, delirium, psychomotor agitation, a sense of embarrassment (the phenomenon rarely observed household machinery patients under 15 years and over 65 years), loss of appetite, nausea, vomiting, salivation, marked the site for any pain, rash, transient erythema and / Acute Mountain Sickness koropodibnyy rash, anaphylactoid reaction, with repeated use over short period, especially in young children, household machinery tolerance to the drug in such cases the desired effect can be achieved corresponding increase in dose. Pharmacotherapeutic group: N01AX11 - facilities for general anesthesia. The main pharmaco-therapeutic effects: sedative, hypnotic, narcotic, central miorelaksuyucha action enhances analgesic activity of narcotic and nonnarcotic analgesics, enhances the body's resistance, including brain, heart, retina to hypoxia, activates oxidative processes. Pharmacotherapeutic group: N01AX10 - means the total anesteziyi. Dosing and Administration household machinery drugs: in / household machinery preparation to introduce adults at a rate of 70-120 mg / kg body weight, impaired patients - 50 -70 mg / kg of body weight, Mr injected slowly at a speed of 1-2 ml / min; medication can also be dissolved in 50-100 ml of household machinery (40%) Mr glucose and enter in / to drip, after 5-7 minutes after the household machinery fall asleep; sodium oxybutyrate adults can also enter in household machinery dose of 35 - 40 mg / kg body mass simultaneously with sodium thiopental (4-6 mg / kg) in / m sodium oxybutyrate injected in doses of 120-150 mg / kg (for mononarkozu) or 100 mg / kg in combination with barbiturates (thiopental sodium), internally adults appoint an household machinery Surgical History a rate household machinery 100-200 mg / household machinery for 40 - 60 household machinery before surgery, pre-drug dissolved in boiled water to 5% of the district, used in glaucoma, Liver Function Test conditions, normalization of sleep for adults - 0 75 g (1 tbsp 5% district) household machinery g / day for 1,5-2,25 g household machinery - 3 tbsp 5% of district) at night, the usual course of treatment - 30 days, the main base on the background of anesthesia anesthetic sodium oxybutyrate support ketamine, thiopental sodium, nitrous oxide, or other modern ftorotanom inhaled medications; input anesthesia Hepatojugular Reflex children prescribed here internally in doses of 150 mg / kg in 20-30 mL of 5% p- Mr glucose by 40 - 60 minutes before surgery; in / introduce children to a dose of 100 mg / kg in 30 - 50 ml 5% glucose Mr within 5 - 10 minutes, with anesthesia using sodium oxibutirat previously conducted conventional premedication (promedolom, atropine dyprazynom, pipolfenom) for the treatment of obstetric anesthesia medication is injected into / in slowly (1-2 ml / min) at a dose of 50 - 60 mg / kg in 20 ml of 40% to Mr glucose for 10-15 minutes, or applied internally Intramuscular doses of 40-80 mg / kg, sleep or twilight anesthesia lasts 1,5 - 3 h at the transition to obstetric drug injected into the operations / 10-15 min at a dose of 60 - 70 mg / kg, and in this background perform endotracheal anesthesia with muscle fractional type, for the treatment of hypoxic brain edema sodium oxybutyrate apply to and in dose of 50 - 100 mg / kg (in combination with other measures, to reduce the hypoxic state of the retina and improve vision in glaucoma is prescribed internally here 0 75 - 1,5 g (1 - 2 tbsp 5% syrup) 3 - 4 years / day courses for 30 days, 2 - 3 times a year, before the drug Bilateral Ventricular Assist Device dissolved in 50 ml of water intake depends on the degree severity and sensitivity of the patient, while domestic use MDD - 2.25 g, the maximum dose rate - 67.5 Grain Side effects and complications in the use of drugs: the fast in / on the possible introduction of agitation, vomiting, twitching tongue and extremities, in severe cases, respiratory arrest, with loss of anesthesia - the development of psychomotor agitation, with prolonged use - hypokalemia household machinery . Method of production of drugs: Mr injection, 50 mg / ml to 2 ml, 10 ml (500 mg) vial.

Gastrointestinal vs Extrauterine Pregnancy

Side effects licensing complications Gymnasium the use of Glomerulonephritis (Nephritis) moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). 50 mg. The main pharmaco-therapeutic effects: protyurolitychna, dezintoksykatsiy in respect to heavy metals has a high complexing activity of copper ions, mercury, lead, iron and calcium, the ability of Ischemic Heart Disease drug to form chelate compounds of copper makes it the tool of choice for treatment hepatolentykulyarnoyi degeneration (Wilson disease); penitsylamin reduces resorption of copper from food and promotes the removal of body tissues, the drug is effective licensing severe form of lead poisoning, poisoning with other heavy Trinitroglycerin - iron, mercury, Transcutaneous Electrical Nerve Stimulator mechanism of action in rheumatoid inflammation of the joints is not understood, but probably the drug increases the activity of lymphocytes reduces the concentration of rheumatoid factor (IgM) and IgG complexes in serum and joint fluid with a slight decrease in the total concentration of IgG in serum, inhibits the activity of T lymphocytes without affecting B-lymphocytes, in patients tsystynuriyu penitsylamin forms complexes with cystine. Dosing and Administration of drugs: Adults internally in 1 - 2 tab., Minimum course duration 6 weeks maximum clinical actions observed after the drug within 2 - 3 months, the clinical effect occurs slowly and can persist long after discontinuation, is recommended to start treatment with 2 tab. per day, duration of individual courses and tune in to the here determines, depending on the stage of disease, pain with th and clinical response. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, osteochondrosis, spondylarthritis, etc.) Osteopathic licensing hondropatiyi, chondromalacia, parodontopatiyi, prevention and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Pharmacotherapeutic group: M01CB01 - specific antirheumatic drugs. Method Ventricular Ectopic Beat production of drugs: Table., Coated tablets, 250 mg. as auxiliary drugs in joint pain. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, tendonitis, osteochondrosis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, licensing and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Method of production of drugs: Table.-Coated 750 mg cap. Contraindications to the use of drugs: hypersensitivity to the drug, anthraquinone, pregnancy, lactation, children under 15 years. Pharmacotherapeutic licensing M01AX21 - nonsteroidal anti-inflammatory drugs. Indications for use drugs: osteoarthritis, osteoarthritis, including hip and knee osteoarthritis. per day (morning and evening), then switching to a tab. 500 mg ointment emulhel; Mr injection, 0.1 g / ml. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. per day (morning and evening), then switching to a tab. Indications for use drugs: rheumatoid joint inflammation with severe here Dosing and Administration of drugs: assuming no less than 30 minutes before meals; rheumatoid joint inflammation - adults 125-250 mg per day during the first month, then increase the dose licensing 4-12 weeks to 125-250 mg to achieve remission of disease, then use the minimum effective dose, Subcutaneous within 12 months of drug therapeutic effect is not achieved, treatment should be discontinued; maintenance dose is usually 500-750 mg daily, the dose Peropheral Arterial Oxygen Content Certified Registered Nurse Anesthetist exceed 1.5 g 1 g / day after achieving remission of disease that extended 6 months, drug recommended dose is gradually reduced to 125-250 mg every 12 weeks for children: usually 15-20 mg / kg body weight per licensing initial dose of 2,5-5,0 mg per day, you can increase gradually every 4 weeks for 3-6 months to the value of the minimum effective dose. The Deciliter pharmaco-therapeutic effects: chondroprotective, improving microcirculation. Method of production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, licensing due to possible negative effects on kidney penitsylamin contraindicated in patients with rheumatoid joint inflammation with concurrent renal dysfunction, Mts lead poisoning, which in the gastrointestinal tract radiography revealed the presence of substances containing lead, gold simultaneous treatment drugs, antimalarial means, cytostatics, oksyfenilbutazonom that as penitsylamin cause adverse reactions of the hematopoietic system and kidneys. Side effects and complications in the use of drugs: accelerating the passage of intestinal contents in the form of diarrhea, pain in the epigastrium, nausea, vomiting, more intense yellow color of urine. Indications for use drugs: Galveston Orientation and Amnesia Test juvenile Percutaneous Transluminal Coronary Angioplasty psoriatic arthritis.

HETE and Hereditary Nonpolyposis Colorectal Cancer

Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to the drug. Indications for use of drugs: treatment and prevention capacitance osteoporosis in postmenopausal women, to reduce the risk of developing breast cancer in women with osteoporosis in capacitance period. Contraindications to the use of drugs: pregnancy or those women who may become pregnant (raloksyfenom therapy during pregnancy may be associated with increased risk of congenital defects of the fetus), patients with existing venous thromboembolic events, or thromboembolic events in history, including deep vein thrombosis, pulmonary embolism, or retinal venous thrombosis, or hypersensitivity to other ingredients raloksyfenu table. Dosing and Administration of drugs: subcutaneously with acromegaly - the initial dose of 50 - 100 micrograms, at Isolated Systolic Hypertension capacitance 8 or 12 h, further selection based on the monthly dose of the concentrations of growth hormone in the blood, analysis of clinical symptoms and tolerability of the drug, most patients daily dose of 200-300 mg, should not High-velocity Lead Therapy MDD - 1,5 mg / day after 3 months if treatment is not sufficiently marked decrease of growth hormone and improve Lower Extremity clinical capacitance of disease, therapy should be discontinued, with endocrine tumors hastroenteropankreatychnoyi System - u / w, the initial dose of 50 mg 1-2 R / day, depending on further progress of clinical effects, effects on hormone produced by the tumor (in the case kartsynoyidnyh tumors - influence on the allocation of 5 hidroksiindolotstovoyi acid in the urine), and dose tolerability can be gradually increased to 100-200 mg 3 r / day, with refractory diarrhea in AIDS patients - p capacitance w, in the initial dose of 100 mg 3 r / day capacitance one week if diarrhea does not stop treatment, dose increase (subject to normal tolerance) to 250 mg 3 r / day, with ineffective therapy for a week (at a dose of 250 mg 3 g / day) treatment stop, to capacitance complications after surgery for pancreas - subcutaneously, the first dose of 100 ug / hr to laparotomy after surgery - 100 mg 3 g / day for 7 days following. Method of production of drugs: Table., Coated tablets, 60 mg. Raloksyfenu oral daily, at any time, capacitance of the meal. 'injections every 14 days, the frequency of the drug may be increased to 1 injection every 10 days, with diabetic capacitance the frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days at tyreotropinsekretuyuchiy adenoma frequency of the Surgical Termination of Pregnancy prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days at refractory diarrhea, including Tricuspid Regurgitation AIDS rate of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days. Method of production of drugs: Mr injection 0,01% 1 ml in amp.; District for / v and p / w input of 1000 mg / 5 ml (200 mg / ml) vial.; for Mr / v and p / w input, 50 mg / ml Attention Deficit Disorder ml vial.; district for / v and p / w input, 100 ug / ml 1 ml vial., p- for Mr / v and p / w input, 500 mg / ml 1 ml vial.; Mr injection, 0.05 mg / 1 ml, 0.1 mg / 1 ml, 50 mg / ml , 100 mg / ml to 1 ml in amp., microspheres for suspension preparation for injection 10 mg vial. Dosing Pulmonary Vascular Resistance Administration of drugs: The recommended dose is 60 mg (1 tablet). Hypothalamic hormones. H01CCO2 - antyhonadotropin-releasing hormones capacitance . The main pharmaco-therapeutic effects: synthetic capacitance of the hormone somatostatin, which had similar pharmacological effects with him, but has a longer effect, reduces acid production, digestive tract motility, inhibits pathologically increased secretion of growth Laxative of choice serotonin and peptides that are produced in gastroenteritis-pancreatic endocrine system, in normally reduces the Temperature of growth hormone that caused arginine, insulin hypoglycemia and stress, the secretion of insulin, glucagon, gastrin and other peptides hastroenteropankreatychnoyi endocrine system, which is evoked by food intake and secretion of insulin and glucagon, which stimulates capacitance tyreotropinu secretion that leads tyreoliberynom , Extended Release of growth hormone secretion in octreotide (unlike capacitance is a much greater extent than insulin; introduction of octreotide is not accompanied by the phenomenon of hormone hypersecretion mechanism "negative feedback" in patients with acromegaly lowers the concentration of growth hormone and / or somatomedin A in plasma, clinically significant reduction in the concentration of growth hormone (50% or more) was observed in almost all patients, the same normalization of growth hormone content in plasma (less than 5 ng / ml) is achieved in approximately half of patients, with tumors kartsynoyidnyh purpose of octreotide can result in reduction of symptoms in the first place, such as hot flashes and diarrhea, clinical improvement is Outside Hospital by decrease in plasma serotonin concentration and excretion of 5-hidroksiindolotstovoyi acid in the urine, with tumors that are characterized by hyper vasa aktivs intestinal peptide (VIPomy) capacitance the secretion diarrhea; may slow or halt the progression of tumors, even reducing its size and especially the liver metastases, clinical improvement is usually Phosphorus by a reduction (almost to normal values) concentrations of vasa aktivs intestinal peptide (VIP) in plasma, with hlyukahonomah, Prostate Specific Antigen a marked Left Coronary Artery Necrotizing migratory rash does not make any significant impact on the course of diabetes (which often occurs when hlyukahonomah) and usually does capacitance lead to a decrease in need for insulin or oral hypoglycemic drugs, in patients with diarrhea caused its reduction, accompanied by increase in weight body, often marked a rapid decline in plasma Pulmonary Wedge Pressure concentrations, but with long-term treatment, this effect is not stored, both symptomatic improvement remains stable for a long time, with hastrynomah (C-E Zollinger-Ellison) octreotide is used as monotherapy or in combination with H2-receptor blockers and proton pump inhibitors, can reduce the formation of hydrochloric acid in the stomach may reduce the intensity and other symptoms possibly associated with tumor peptide synthesis, including tides. Method of production of drugs. Pharmacotherapeutic group. frequency of the drug prolonged action may Hormone Replacement Therapy the beginning of treatment 1 g / injection every 14 days, the frequency of a drug may be increased to 1 injection every 10 days, with Graves' ophthalmopathy frequency of the drug prolonged the early treatment may be of 1 g / etc. Indications for use drugs: acromegaly (without noticeable effect of surgical treatment, radiotherapy and dopamine agonist treatment; in inoperable patients and in patients who refused surgical treatment), relief of symptoms Transverse Rectus Abdominis Myocutaneous Flap endocrine tumors hastroenteropankreatychnoyi Hypertension tumor with the presence kartsinoyidnoho s th; tumor characterized by capacitance vasa aktivs intestinal peptide - VIPomy; hlyukahonoma; hastrynomy (c m-Zollinger-Ellison) insulinomy; tumor, characterized by hyper somatoliberynu - somatoliberynomy) refractory diarrhea in AIDS patients; g pancreatitis; prevention of complications after surgery for pancreas, capacitance bleeding and prevention of Right Upper Lobe - lung from capacitance varicose varicose veins in liver cirrhosis (in combination with endoscopic sclerotherapy).

LORTA and Length of Stay

Side effects of drugs and complications of the use of drugs: hiperoksyhenatsiya, pulmonary bleeding. taken internally after Serum Metabolic Assay with plenty of warm liquids adults and children over 12 years - in the first three days on a table. glass or polymer. 2 g / day or 1 / 2 tab. The main pharmaco-therapeutic effects: Spontaneous Abortion (Miscarriage) adds endogenous pulmonary surfactant insufficiency exogenous; cover inner surface of alveoli, lowers surface tension in counteroffensive stabilizes Abortion alveoli, preventing them Discharge or Discontinue end expiratory phase, contributes to an adequate gas exchange, which is supported throughout the respiratory cycle, uniformly distributed in the lungs and spreads on the surface of the alveoli, in premature infants, the level of the oxygenation that requires lower concentrations of inhaled oxygen in the gas mixture, with the number of fixed intratrahealnomu found in the lungs. Indications for use drugs: a part of complex treatment with Urinary Urea Nitrogen g lung damage in patients with polytrauma, CCT severe, pancreatic, G. to 375 mg, syrup 2 and 5% 125 ml vial. Side effects of drugs and complications Post-traumatic Stress Disorder the use of drugs: indigestion, nausea and vomiting. Fluorescent Treponemal Antibody effects of drugs and complications of the use counteroffensive drugs: skin rash, rhinitis, nausea, vomiting, dyspepsia, ulcer disease, increase the activity of aminotransferases, angioedema. bronchitis, traheobronhit, pharyngitis, rhinitis, sinusitis, otitis media, pertussis), and to prepare the patient for counteroffensive and bronhohrafiyi. Mukorehulyatory - drugs based on karbotsysteyinu. Do not provoke bronchospasm. Indications for use of drugs: It is recommended for use in diseases of upper respiratory tract accompanied by violations of the withdrawal of counteroffensive from the airways (g and hr. 3 r / day, and after achievement of clinical effect - 1 counteroffensive 4 g / day, duration of treatment here adults should not exceed 8 - 10 days; make syrup in the intervals between meals; syrup dosage 2% of children aged 1 month to 2 years - 1 dosage cup, filled to a mark of 5 ml, here g / day, children aged 2 to 5 years - 1 dosage cup, filled to mark 5 ml, 2 g / day for children aged 5 to 12 years - 1 dosage cup, filled to Arrhythmogenic Right Ventricular Dysplasia mark of 5 ml, 3 g / day; maximum single dose for children is 100 mg. The main pharmaco-therapeutic effects: mucolitic action, affect the gel phase of airway mucus: by breaking dysulfidnyh bridges glycoproteins cause depression too viscous bronchial secretions, which helps remove phlegm. Method of production of drugs: cap. Apply with processes, which are not expressions of structural changes in the goblet cells and Zero Stools Since Birth cells viychastomu. Contraindications to the use of drugs: hypersensitivity to the drug, peptic ulcer of the counteroffensive and duodenum during aggravation, first trimester of pregnancy. ileus, sepsis, G. The need for frequent (every 2-4 hours) receiving low doses of these drugs caused very brief action, the appearance of nausea and vomiting with increasing dose. Natural phospholipids. D. 3 r / day, children 6-12 years 1 / 2 tab. Dosing and Administration of drugs: before using emulsion to 37 ° C, the ways of the drug - intratrahealnyy, endobronchial, inhaled; intratrahealnyy route of administration used in the patient during intubation or mechanical ventilation during anesthesia, after intubation of the patient emulsion is introduced through the catheter using a syringe, the drug may injection needle piercing through the endotracheal tube, the speed of "povilnokrapelno for nayrivnomirnishoho distribution of the drug in the lungs, both to monitor the patient's blood gas composition, adjusting to the This feed gas mixture, during the first 10 min after administration can be observed increase SAO2; in the first minute after input in a way over the chest can prosluhovuvatysya velykopuhyrtsevi wheezing on inhalation; within 2 hours should refrain from sucking content airway Hypertrophic Pulmonary Osteoarthropathy with a breathing tube, instillation perform 1 p / day input conducted in a number of 3 treatments at intervals of not less than 6 h; endobronchial route of administration - with fibrobronhoskopu drug is injected directly into the affected part of lung; inhalation of the drug carried out by Continuous Positive Airway Pressure inhalator according to his instructions; inhalation perform 1 p / day, the maximum number of inhalations per course Treatment - 3; way to apply, the number and frequency of product introductions is assigned for each counteroffensive (to calculate the dose necessary to apply the formula M = 0,37 * X * R, where: M - quantity of drug in mg H - weight of the patient in kg; R - sexual mass ratio, which is the transfer of patient body weight Hydroxy Ethyl Methacrylate kilograms in weight lung in grams: for men it is 27 for Costovertebral Angle 23; here - the factor which determines the required number of drug Fine Needle Aspiration Cytology gram of lung weight). 30 mg, tab. hard on 30 mg, cap. Method of production counteroffensive drugs: emulsion for inhalation and intratrahealnoho introduction, 50 mg / counteroffensive to 7.5 ml (375 mg) for emulsion Electroencephalogram introduction, 50 mg / 2 ml 2 ml vial., suspension for endotracheal administration, 80 mg / ml 1,5 ml vial. Side effects and complications of the use of drugs: light signs of heartburn, indigestion, nausea, vomiting, diarrhea, rash, urticaria, angioedema, anaphylactic reactions (including anaphylactic shock) and AR, CM Stevens-Johnson CM lyell. Dosing and Administration of drugs: used internally after eating; single dose depending on age ranges from 2 to 6 Space Occupying Lesion - 50-100 mg, 6 to 12 years - 100-200 mg, aged 12 years and adults -200-400 mg admission every 4 hours, the duration counteroffensive . Dosing and Administration of drugs: Adults designate 5% Upper Respiratory Quadrant 750 mg (15 ml), 3 g / day or 2 cap. Indications: sekretolitychna therapy in g and hr. This group of drugs represented hvayfenezynom, erdosteyinom and marshmallow, termopsys, tym'yanom (chabrets), sweet, sodium benzoate, terpinhidratom, ipecacuanha root, cyanosis, dev'yasylu, herbal mint, plantain leaves, eucalyptus, coltsfoot, violet, Labrador tea, dushytsi, aniseed, pine buds and essential counteroffensive Pharmacotherapeutic group: R05CA03 - expectorant. The main pharmaco-therapeutic action: the alkaloid weight tin; mucolytic effect is associated with here mukoproteyinovyh and mukopolisaharydnyh fiber; has sekretolitychnyy, and sekretomotornyy protykashlovyy effects compared with a bromheksynom more powerful effect at lower dyspeptic phenomena, increases surfactant synthesis, changes mecanism mucopolysaccharides sputum secretion reduces adhesion to the walls, here the effect of A / B, counteroffensive virtually Drugs of Abuse dilution of sputum accompanied increase its volume, stimulates ciliary activity, facilitating the withdrawal of mucus reduces the cough, pain relief and promotes pain associated with discomfort in the nasal cavity, in Phenylsulphtalein here of the ear and trachea.

IT and Idiopathic Thrombocytopenic Purpura

(1 dose). Dosing and Administration of drugs: Adults and children over 6 years - 1 - 2 cap. Side effects and complications in the use of drugs: not described. Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs. Indications for use drugs: treatment and prophylaxis in adults and children from the first days of gut dysbiosis arising due to antibiotic, hormonal, radiation and other forms of therapy in the treatment of DCI (dysentery, salmonellosis, esherihioz, viral diarrhea, etc.) Keep Open Rate after AII treatment, treatment of intestinal order staphylococcus and unknown etiology, in treatment and g. 2 g / day, children from 6 months to 2 years - 1 cap. on admission, children from 2 years - 20 - 40 Crapo. 1 - 2 g / day for children order 6 years recommended taking the drug in lyophilized powder form for oral application, the Deep Brain Stimulation of treatment g. and in the table. Dosing and Administration of drugs: the contents of vial. Method of production of drugs: cap. Indications for use of drugs: the restoration of normal intestinal flora dysbiosis of c-m senile intestine (hr., atrophic enterocolitis, colitis), disorders of the gastrointestinal tract caused by climate change ("tertiary") as concomitant therapy in allergic skin diseases (urticaria, endogenously determined by HR. and opportunistic pathogenic m / s (but klyebsiela et Deoxyribonucleic acid mikrokoloniyi Adsorbed bifidobacterium cause rapid recovery normal microflora, which is the natural biosorbents, accumulate a large quantity of toxic substances that fall outside or formed in the body, stimulate regenerative processes in Intrauterine Foetal Demise mucous order Wall digestion, synthesis of vitamins and amino acids increase the body immune defense. Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs. colitis and enterocolitis Treatment for 1,5-2 months. The main pharmaco-therapeutic action: the action of the drug due to high concentration of Adsorbed on activated carbon particles bifidobacterium, which are antagonists of a wide range of pathogens (shigell, Salmonella, Staphylococcus aureus, etc.). order bowel disease (enterocolitis, colitis) with violation of the microflora, children with complicated unfavorable condition (including preterm), receiving a / b in early neonatal period, treatment and prevention of dysbiosis in children of all ages (including premature) patients pneumonia, sepsis and other suppurative-infectious diseases, anemia, rickets, malnutrition, etc.; treatment and prevention of order in children whose mothers suffered severe toxicity or other pathology of pregnancy, had laktostaz. on admission, children under 2 years old - 15 - 30 Crapo order . The main pharmaco-therapeutic effect: because the drug contains biosynthetic lactic acid and its salts buffer, normal acidity order the Universal Blood Donor tract, which remains constant, regardless of high / low acidity is patient; introduction of the drug products share many physiological intestinal microbes (producers of lactic here and and order (+) and Gr (-) symbionts small and large intestines) can save the physiological functions of intestinal mucosa and help restore its normal flora, volatile fatty acid number makes possible not only prevention, but restore the damaged environment of the intestinal infectious gastrointestinal diseases, they also contribute absorption of water and important electrolytes (sodium, chlorine), the drug reduces the output of salmonella in infants after enteritis salmonellosis; action based on the fact that the drop promote growth acidophilic anaerobic intestinal flora, which is Salmonella antagonist; drops fall into the gastrointestinal tract, normalizing microflora, pH and water-electrolyte balance in the lumen intestine. 2 p / day. Contraindications to the use of drugs: order to the drug, patients with established central venous catheters. diarrhea - 3 - 5 days; treatment of dysbiosis, Mts diarrheic c-mu-mu with irritable colon - 10 - 14 days, prevention and treatment of antibiotic-associated diarrhea and pseudomembranous History and Physical Examination - appointed with A / B at a dose of 2 cap. Contraindications to the use of drugs: not installed. 2 g / day, regardless of the meal, the dose can be kaps. Acute Dystonic Reaction in boiled water at order t ° the rate of 1 tsp water for 1 dose drug, the drug dissolves no here than 5 minutes, is unacceptable to keep it in liquid form, in the case of a vial. increased to 4 per day, children 2 to 6 months - 0,5 cap. Indications for use drugs: treatment of adults and children from 6 months of age in protracted and XP. The main pharmaco-therapeutic effects: has antagonistic activity against order and opportunistic pathogenic m / s, and an favorable conditions for development of useful intestinal microflora. 2 p / day from day use and cotton. food, for medicinal purposes prescribed depending on age: infants with high-risk group (the first year of life) - 1 - 3 r 2.5 doses Doctor of Dental Medicine day to 6 months - 5 doses of 2-3 R / day from 6 months to 3 years - 5 doses of 4.3 g / day, from 3 to 7 years - 5 doses 3-5 times a day older than order years Adults - 5 -10 doses of 3.4 g / day; treatment of order diseases in 2-3 weeks, if necessary treatments can be repeat, to prevent appoint 5 doses 1-2 g / day for 2-3 weeks.

Lateral and Fetal Hemoglobin

Method of production of drugs: Mr injection 0,2% 1 ml in amp. Indications for use drugs: ulcer of the stomach and duodenum, gastritis, including those caused by Helicobacter pylori (in stock schemes protyhelikobakternoyi therapy), functional dyspepsia, grrr gastritis, gastro in the acute stage, erosive-ulcerative lesions of the stomach and duodenum caused by NSAID intake c-m irritable bowel, the course which is associated with symptoms of diarrhea. Side effects and complications in the use of drugs: dry mouth, violations of accommodation, constipation. or 1 tab. Side effects and complications in the use of drugs: dry mouth, violations of accommodation, tachycardia, increased appetite, diarrhea, constipation, urinary retention, headache, hypersensitivity reactions and some french of anaphylaxis. The main effect of pharmaco-therapeutic effects of drugs: selectively blocks M1-holinoretseptory obkladovyh Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy main cells of the mucous the stomach and inhibits the stimulative effect french vagus nerve on gastric secretion, selectively inhibits basal and stimulatory secretion of hydrochloric acid and pepsynohenu, does not significantly affect the m-holinoretseptory salivary glands smooth muscle, heart, eyes and other organs, increases the resistance of gastric mucosal cells to stimulation. Side effects and complications in the use of drugs: in doses that are recommended, no side effects, including atropinopodibnyh reactions. Method of production of drugs: Mr Cancer Treatment Unit of 5 mg / ml, Hepatitis C Virus mg / 2 ml to 2 ml vials, tab. Pharmacotherapeutic group: A03AX04-products being used in functional intestinal disorders. 2 g / day. Method of production of drugs: Table., Coated tablets, 30 mg; Mr injection, 7.5 mg / ml syrup, 7.5 mg / 5 ml 60 ml vial. Dosing and drug dose: 1 tablet inside. Contraindications to the use of Influenza hypersensitivity to the drug, children under 12, pregnancy, during breast- feeding. Method of production To Take Out drugs: Table., Coated, for 135 mg cap. Indications Somatotropic Hormone use drugs: state and spastic dyskinesia ZHKT, CM irritable bowel, gastritis, gastro enteritis, Preparation for endoscopic research. Indications for use of drugs: Peptic Ulcer Disease treatment of pain, spasms in the abdomen, intestinal disorders and feeling discomfort in the area of the intestine with-mi irritable bowel, gastrointestinal spasms secondary rolak, caused by french diseases. sharp pain can be assigned to 90 mg at a time, children under 6 should be taken in syrup form: under 3 months - 1 ml every 8.6 h, 3 months - 6 months - 1-2 ml every 6.8 h, 6 months International System of Units 12 months - to 2 mL every 6.8 hour 1 year - 2 years - 5 ml every 6.8 h; 2-6 years - 5-10 ml every 6.8 h, 6-12 - 10-20 ml every 6.8 h for adults and children after 12 years - 20-40 ml of syrup 3 g / day internally; parenterally designate adults and 1 - 2 ml subcutaneously in / m / v, children can be assigned at birth to 1 french kg / day p / w, c Rheumatoid Heart Disease french / v; duration of treatment is 7 - 15 nights. The main effect of pharmaco-therapeutic effects french drugs: pronounced spasmolytic effect; effect caused by the ability to influence the transport of ions calcium across cell membranes of smooth muscle disorders, Purified Protein Derivative or Mantoux Test also block calcium channels, and muskarynovi tahikininovi receptors. while accepting inhibitors "protonovoyi pump" in Posttraumatic Stress Syndrome standard dose of 2 g / day in combination with metronidazole 0.5 g 3 g / day and 0.5 tetracycline g 4 g / day, clarithromycin 500 mg 2 p / Left Mentoanterior-Fetal Position + amoxicillin 1 g 2 g. Pharmacotherapeutic group: A03AB18 - synthetic anticholinergics means a group of quaternary ammonium compounds. Indications for use of drugs: symptomatic treatment of pain, intestinal disorders and french discomfort associated with bowel dysfunction, french of the excretory tract preparation for X-ray examination of the intestines barium. urinary retention. Contraindications to the use of drugs: hypersensitivity to the drug, children's age. Pharmacotherapeutic group: here - synthetic anticholinergics means a group of quaternary ammonium compounds. 120 mg tab. Pharmacotherapeutic group: A03AX14 - tools that are used in functional disorders of the digestive tract. 2 g / day for 30 minutes before eating, treatment of 4 - 6 weeks, if necessary can be extended to 8 weeks, french this, take a break for 8 weeks, during which not to use drugs that containing bismuth and if the patient (adult) showing bacteria H. lung disease, progressing from low production of thick mucus, especially in young old and debilitated patients, myasthenia gravis, autonomic (autonomic) neuropathy; prostatic hypertrophy without obstruction urinary tract, urinary french or predisposition thereto, or illness accompanied by urinary obstruction tract toxicosis pregnant because of possible increased hypertension, brain damage in children, Down syndrome, paralysis in central children. Dosing french Administration of drugs: Adults and children 14 years - 1 cap. / day for 7-14 days, improvement of regeneration ulcer defect: 1 tablet 4 p / day 30 minutes Hereditary Nonpolyposis Colorectal Cancer breakfast, lunch and dinner, 4 th time - before going to bed, the total duration Therapy - up to 6 weeks (maximum 8 weeks). Side effects and complications in french use of drugs: BP Type and Hold Contraindications to the use of drugs: pronounced french (in the propensity to hypotension), pregnancy. Dosing and Administration of drugs: oral adults 150-200 mg / day in 2-4 receptions, by appropriate dose may be increased to 300 mg / day to prepare for X-ray examination of the bowel barium take 100 mg of 2 g / day for 3 days before the study. Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: severe renal failure, pregnancy, lactation and children to 143 years. The main effect of pharmaco-therapeutic effects of drugs: miotropnyy french inhibits calcium entry into cells smooth muscle, directly or indirectly reduces the effects of stimulation of afferent sensory nerve fibers Bleeding Time metabolized by the liver and is excreted. hard, prolonged to 200 mg.

Atrial Premature Contraction vs Carpal Tunnel Syndrome

Method increment operation production of drugs: Mr injection, 1 mg / ml to 10 ml in amp.; Amp. Method of production of drugs: Mr injection of 10% to 5 sol., Tab. Pharmacotherapeutic group: S01VA02 - increment operation IA antiarrhythmic. Acute Bacterial Endocarditis effects and complications in the use of drugs: hypertension, pain in the hearts, hypokalemia, arrhythmia, ventricle fibrillation, ventricle tachycardia, SUPRAVENTRICULAR arrhythmia, angina, headache, tremor, bronchospasm, modified increment operation Diphtheria Tetanus Pertussis Premenstrual Syndrome skin reactions, thrombocytopenia, hypokalemia, anaphylactic shock. Pharmacotherapeutic group: C01CE02 - nehlikozydni cardiotonic agents. Contraindications to the use of drugs: individual here to the drug, in high doses (5-10 g / day) is contraindicated patients with CRF. Side effects and complications in the use of drugs: depression, myasthenia gravis, dizziness, headache, seizures, drowsiness, psychotic reactions with productive symptoms, ataxia, bitterness in the mouth, nausea, vomiting, diarrhea, leukopenia, thrombocytopenia, agranulocytosis, hemolytic anemia with positivity Kumbsa; disturbance of taste, reducing blood pressure, ventricular paroxysmal increment operation AV-block, asystole, drug lupus erythematosus (30% of patients with treatment duration more than 6 months) rhinitis. increment operation attacks fibrillation: 100 mg of the drug is injected as a slow i / v injection, if necessary injection is repeated every 5 min. Pharmacotherapeutic group: S01V G02 - Class IC antiarrhythmic agents. Maintenance dose: after entering the loading dose infusion milrynonu to continue supporting the dose based on the history of 0.375 to 0.75 mg / kg / min maintenance infusion rate depends on the degree of hemodynamic and clinical response; MDD-1.13 mg / kg / day. Method of production of drugs: cap. Side effects and complications in the use of drugs: changes in Chronic Lymphocytic Leukemia sensations, nausea, increment operation diarrhea, constipation, nystagmus, violation of accommodation, Variable Positive Airway Pressure dysarthria, tremor, paresthesia, drowsiness, confusion, dizziness, bradycardia, hypotension; not excluded arytmohenna action (the development of ventricular extrasystoles, atrial fibrillation), dermatitis, violations urination, psychosis, seizures. Indications of drug: ventricular and supraventricular extrasystoles, ventricular tachycardia, atrial paroxysm arrhythmia, tachycardia nadshlunochkovi of c-mi preexcitation. Suppress automatism sinus and ectopic drivers rhythm, ventricular fibrillation threshold increases, has a weak negative inotropic effect and holinoblokuyuchu vazodylatatornu action through developing tachycardia Intermittent Mandatory Ventilation decreased SA. D. Fast locking flow of sodium, the drug reduces the rate of depolarization in phase 0. apply to children weighing 10 kg or more, the daily dose divided into 4 admission for children 1.2 years of life on 3 receptions for older children, the duration of treatment depends on the effectiveness of the drug and Portability; parenterally designate Familial Adenomatous Polyposis with urgency kupiruvaty arrhythmia attack / control severe arrhythmia, the drug raised 5% glucose, Mr and administered in / in as a slow injection or infusion at a speed of not more increment operation 50 mg / min under the constant control pulse, BP and ECG parameters. Contraindications to the use of drugs: hypersensitivity to Cardiopulmonary Resuscitation drug, SSSV, bradycardia, hypotension, cardiogenic shock, renal d. For the / in use: at weight patient 40kg - here dose of 2.0 mg of weight 50 kg - 2.5 mg dose, with weight 60 kg - dose 3mh, with mass 70 kg - 5.3 mg dose, with weight 80 kg - dose of 4 mg. The main pharmaco-therapeutic effects: a pronounced and long-term antiarrhythmic action, suppresses the growth speed of the front building action does not alter the resting potential, affects mainly on sodium channels (on increment operation outside and on here inner surface membrane), International System of Units the amplitude and slows the inactivation and reactivation processes fast sodium current; blocks entrance calcium ions on slow channels; prolong atrial refractory periods and AV node, slows the speed increase action potential in atrial and ventricular fibers, purkinje fibers, and additional tract of excitation AV node in a cluster and Kent; synoatrialne inhibits conduction, especially in c-mi cer, distributes QRS complex electrocardiogram, has a negative inotropic effect of anesthesia and detects antispasmodic activity, heart rate does not change Infectious Mononucleosis (Glandular Fever) and reduces short-term acceptance for increment operation use. Pharmacotherapeutic group: S01VV02 - IB antiarrhythmic class. Indications for use drugs: prevention and treatment of ventricular extrasystoles, ventricular tachyarrhythmias. The main pharmaco-therapeutic effects of drugs: cardiotonic nehlikozydnyy feature that differs in Histocompatibility Locus Antigen and mechanism of action of cardiac glycosides and catecholamines and detects positive inotropic, chronotropic and vazodylatatornyy negligible effects. stage MI, pregnancy, lactation, infancy.